Medications To Treat Stimulant Use Disorder Led To Abstinence For 13% & Reduced Use For 31%

Among 2,000 adults enrolled in pharmacotherapy trials for cocaine or methamphetamine use disorder, 31.2% achieved reduced stimulant use and 13.3% achieved abstinence by the end of their respective trials, according to a recent study. Among those receiving active medication specifically, 32.5% achieved reduced use compared with 29.3% of those receiving placebo, and abstinence rates were 13.6% for active treatment compared with 12.7% for placebo.

The study pooled harmonized, individual-level data from 12 multisite randomized controlled trials (RCTs) sponsored by the US National Institute on Drug Abuse (NIDA) and conducted between 2001 and . . .